[Clinical experience concerning the action of a new oral antidiabetic drug: glidiazinamide].
D000328:Adult; D000368:Aged; D002784:Cholesterol / Q000097:blood; D003510:Cyclohexanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use*; D014508:Urea / Q000627:therapeutic use*
D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D011719:Pyrazines; D013450:Sulfones; D014508:Urea; D002784:Cholesterol
Esperienze cliniche sull'azione di un nuovo antidiabetico orale: la glidiazinamide.